DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...

Annie Antar, MD, PhD, spoke about how long viral clearance could be an indicator of long COVID, but more research would need to be done to confirm this.

The AACR poster will be available on ImCheck’s corporate website after the poster sessions have been opened.

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...

Why didn’t analysts share the same fear that gripped investors about Sarepta stock? One reason is the known risk of acute liver injury associated with adeno-associated virus vector (AAV)-based gene ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

indicating that immune-based therapies could transform HIV treatment. The trial focused on broadly neutralizing antibodies (bNAbs), long-acting therapies designed to target and control the virus.

Proteins play a key role in the life sciences -- from basic research and biotechnological applications to the development and manufacturing of pharmaceuticals. Scientists have developed a method that ...

“Antibody-mediated rejection remains a significant challenge in kidney transplantation, with limited safer and effective treatment options currently available. With the potential to be ...

These two cell types have different roles. B lymphocytes produce antibodies and help alert the T lymphocytes. T lymphocytes destroy compromised cells in the body and help to alert other leukocytes.

The company has dramatically reduced the cost of CMV prophylaxis by 91 per cent, bringing down the monthly treatment price from over ₹5 lakh to a substantially more affordable level. ANVIMO is ...

Cytomegalovirus (CMV) infection/reactivation has ... Consider the benefit versus risks of treatment with a PD-1/PD-L1 blocking antibody prior to or after an allogeneic HSCT. Embryo-Fetal Toxicity ...